Generalized linear mixed model approach for analyzing water, sanitation, and hygiene facilities in Bangladesh: Insights from BDHS 2022 data. [PDF]
Mim MS, Rahaman ML, Sajib AH.
europepmc +1 more source
Mixed-model results for high-intensity distance (per 90 min).
James J. Collins (376190) +5 more
openalex +1 more source
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta +10 more
wiley +1 more source
Acute Decrease in Glenohumeral Internal Rotation During Repetitive Baseball Pitching Is Associated with Transient Structural Changes in Medial Longitudinal Arch of Stride Leg: Pilot Study Using Mixed Model. [PDF]
Abekura T +10 more
europepmc +1 more source
Modeling of Mixed Logical Dynamical (MLD) Model to Hybrid Three Tank System
Vinod Phani +2 more
openalex +1 more source
Dynamic Behavioral Mixed-Membership Model for Large Evolving Networks [PDF]
Ryan A. Rossi +3 more
openalex +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Modeling soybean growth: A mixed model approach. [PDF]
Delattre M, Toda Y, Tressou J, Iwata H.
europepmc +1 more source
Penalized mixed models to adjust for batch effects and unobserved confounding in high dimensional regression [PDF]
Y. J. Lu, Patrick Breheny
openalex +1 more source
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek +2 more
wiley +1 more source

